Other References of Possible Interest

Hewitt WL, Finegold SM. Laboratory studies with kanamycin. Ann NY Acad Sci. 76:122-128, 1958.

Finegold SM, Kudinoff Z, Kendall HO, Kvinge VE. Laboratory and clinical studies with sulfadimethoxine: a preliminary report. Ann NY Acad Sci. 82:44-50, 1959.

Finegold SM, Monzon O, Sweeney EE, Dangerfield HG, Blackman B, Hewitt WL. Laboratory experiences with dimethoxyphenyl penicillin. In: Dimethoxyphenyl Penicillin Symposium. Syracuse, NY: State University of New York College of Medicine, 1961, p. 26-36.

Gordon HE, Gaylor DW, Richmond DM, Clarke JS, Finegold SM. Operations on the colon - the role of antibiotics in preoperative preparation. Calif Med. 103:243-246, 1965.

Finegold SM, Miller LG, Posnick D, Patterson DK, Davis A. Nalidixic acid: clinical and laboratory studies. Antimicrobial Agents and Chemotherapy--1966. Ann Arbor, MI: American Society for Microbiology, 1967, p. 189-197.

Finegold SM, Ziment I. Sulfonamides, nitrofurans and nalidixic acid. Pediatr Clin North Am. 15:95-105, 1968.

Finegold SM. Intestinal bacteria. The role they play in normal physiology, pathologic physiology, and infection. Calif Med. 110:455-459, 1969.

National Academy of Sciences -- National Research Council Division of Medical Sciences Drug Efficacy Study. Fixed combinations of antimicrobial agents. N Engl J Med. 280:1149-1154, 1969.

Finegold SM. The significance of the intestinal microflora. Del Med J. 42:341-345, 350, 1970.

Sabbaj J, Sutter VL, Finegold SM. Urease and deaminase activities of fecal bacteria in hepatic coma. In: Antimicrobial Agents and Chemotherapy--1970, Bethesda, MD: American Society for Microbiology, 1971, p. 181-186.

Finegold SM. Peritonitis, Chap. 70 In: Hoeprich P, ed. Infectious Diseases, New York: The Hoeber Medical Division, Harper and Row, 1972, p. 689-692.

Finegold SM. Appendicitis and diverticulitis, Chap. 71 In: Hoeprich P, ed. Infectious Diseases, New York: The Hoeber Medical Division, Harper and Row, 1972, p. 693-698.

Finegold SM. Pylephlebitis and liver abscess, Chap. 72 In: Hoeprich P, ed. Infectious Diseses, New York: The Hoeber Medical Division, Harper and Row, 1972, p. 699-702.

Finegold SM, Dineen P. Subphrenic abscess and other intraabdominal infections, Chap. 73 In: Hoeprich P, ed. Infectious Diseases, New York: The Hoeber Medical Division, Harper and Row, 1972, p. 703-708.

Sutter VL, Sugihara PT, Finegold SM. Rifampin-blood-agar as a selective medium for the isolation of certain anaerobic bacteria. Appl Microbiol. 22:777-780, 1971.

Nastro LJ, Finegold SM. Bactericidal activity of five antimicrobial agents against Bacteroides fragilis. J Infect Dis. 126:104-107, 1972.

Sabbaj J, Sutter VL, Finegold SM. Comparison of selective media for isolation of presumptive group D streptococci from human feces. Appl Microbiol. 22:1008-1011, 1971.

Bricknell KS, Finegold SM. A simple, rapid method to process and assay fatty acids and alcohols by gas chromatography. Anal Biochem. 51:23-31, 1973.

Bartlett J, Finegold SM. Anaerobic pleuropulmonary infections. Medicine. 51:413-450, 1972.

Bartlett JG, Sutter VL, Finegold SM. Treatment of anaerobic infections with lincomycin and clindamycin. N Engl J Med. 287:1006-1010, 1972.

Sutter VL, Finegold SM. Antibiotic susceptibility testing of anaerobes, Chap. XI In: Balows A, ed. Current Techniques for Antibiotic Susceptibility Testing. Springfield, IL: Charles C. Thomas, 1974, p. 109-118.

Sapico FL, Emori HW, Smith L DS, Bluestone R, Finegold SM. Absence of relationship of fecal Clostridium perfringens to reheumatoid arthritis and rheumatoid variants. J Infect Dis. 128:559-562, 1973.

Attebery HR, Sutter VL, Finegold SM. Normal human intestinal flora, Chap. X In Balows A, DeHaan RM, Dowell VR Jr, Guze LB, eds. Anaerobic Bacteria: Role in Disease, Springfield, IL: Charles C. Thomas Co., 1974, p. 81-97.

Ueno K, Sugihara PT, Bricknell KS, Attebery HR, Sutter VL, Finegold SM. Comparison of characteristics of gram-negative anaerobic bacilli isolated from feces of individuals in Japan and the United States, Chap. XIII In Balows A, DeHaan RM, Dowell VR Jr, Guze LB, eds. Anaerobic Bacteria: Role in Disease. Springfield, IL: Charles C. Thomas Co., 1974, p. 135-148.

Sugihara PT, Sutter VL, Attebery HR, Bricknell KS, Finegold SM. Isolation of Acidaminococcus fermentans and Megasphaera elsdenii from normal human feces. Appl Microbiol. 27:274-275, 1974.

Sutter VL, Tally FP, Kwok Y-Y, Finegold SM. Activity of doxycycline and tetracycline versus anaerobic bacteria. Clin Med. 80:31-38, 1973.

Finegold SM, Attebery HR, Sutter VL. Normal intestinal flora: Makeup and possible relation to bowel cancer. In: Clarke JS, moderator Specialty Conference, Bacteriology of the Gut and its Clinical Implications. West J Med. 121:392-395, 1974.

Finegold SM, Sutter VL, Attebery HR, Rosenblatt JE. Isolation of anaerobic bacteria, Chap. 38 In: Lennette EH, Spaulding EH, Truant JP, eds. Manual of Clinical Microbiology, 2nd edit., Washington DC: American Society for Microbiology, 1974, p. 365-375.

Sutter VL, Attebery HR, Finegold SM. Gram-negative nonsporeforming anaerobic bacilli, Chap. 41 In: Lennett EH, Spaulding EH, Truant JP, eds. Manual of Clinical Microbiology, 2nd edit., Washington DC: American Society for Microbiology, 1974, p. 388-395.

Finegold SM. Intra-abdominal, genito-urinary, skin and soft tissue infections due to nonsporeforming anaerobic bacteria, Chap. 8 In: Phillips I, Sussman M, eds. Infection with Non-sporing Anaerobic Bacteria, a Symposium of the British Society for Antimicrobial Chemotherapy, London, February 26, 1974. Edinburgh: Churchill-Livingstone, 1974, p. 160-187.

Bartlett JG, Finegold SM. Anaerobic infections of the lung and pleural space. Am Rev Respir Dis. 110:56-77, 1974.

Finegold SM, Hewitt WL. Antibiotics: a ready reference to antimicrobial chemotherapy. Outline guide. Hosp Physician 10:26-46, 1974.

Sutter VL, Finegold SM. Susceptibility of anaerobic bacteria to carbenicillin, cefoxitin and related drugs. J Infect Dis. 131:417-422, 1975.

Finegold SM. Anaerobic infections of the abdomen and pelvis. Cleve Clin Q. 42:113-123, 1975.

Sutter VL, Finegold SM. Anaerobic bacteriology: a practical approach for the clinical laboratory. Training program, including videotape, slides and workbook. Professional Education Series, American Society of Clinical Pathologists, 1975.

Sutter VL, Finegold SM. Rosamicin: In vitro activity against anaerobes and comparison with erythromycin. Antimicrob Agents Chemother. 9:350-351, 1976.

Finegold SM. Peritonitis, Chap. 78 In: Hoeprich P, ed. Infectious Diseases, 2nd edit., New York: The Hoeber Medical Division, Harper and Row, 1977, p. 669-672.

Finegold SM. Appendicitis and diverticulitis, Chap. 79 In: Hoeprich P, ed. Infectious Diseases, 2nd edit., New York: The Hoeber Medical Division, Harper and Row, 1977, p. 673-677.

Finegold SM. Pylephlebitis and liver abscess, Chap. 80 In: Hoeprich P, ed. Infectious Diseases, 2nd edit., New York: The Hoeber Medical Division, Harper and Row, 1977, p. 678-681.

Finegold SM, Dineen P. Subphrenic and other intra-abdominal abscesses, Chap. 81 In: Hoeprich P, ed. Infectious Diseases, 2nd edit., New York: The Hoeber Medical Division, Harper and Row, 1977, p. 682-687.

Finegold SM. Anaerobic Bacteria in Human Disease. New York: Academic Press, 1977, 710 pp.

Finegold SM. Therapy for infections due to anaerobic bacteria: an overview. J Infect Dis. 135 (Suppl.):S25-S29, 1977.

Wilson SE, Klein RA, Busch DF, Finegold SM. Intraabdominal sepsis in surgical patients: Evaluation of doxycycline plus gentamicin. In: Finegold SM, ed. Doxycycline (Vibramycin): Recent Investigations and Clinical Experience, Vol. 3. Princeton, NJ: Excerpta Medica, 1977, p. 38-50.

Klein RA, Busch DF, Wilson SE, Flora DJ, Finegold SM. Doxycycline in abdominal surgery. JAMA. 238:1933-1935, 1977.

Sutter VL, Finegold SM. In vitro studies with metronidazole against anaerobic bacteria. In: Finegold SM, McFadzean JA, Roe FJC, eds. Metronidazole. Princeton, NJ: Excerpta Medica, 1977, p. 279-285.

Finegold SM, Shepherd WE, Spaulding EH. Practical Anaerobic Bacteriology. Cumitech # 5. Washington DC: American Society for Microbiology, April, 1977, 14 pp.

Finegold SM, Martin WJ, Scott EG. Bailey and Scott's Diagnsotic Microbiology, 5th ed. St.Louis: C.V. Mosby Co., 1978, 514 pp. (plus instructor's manual, 24 pp.) (Foreign edition: Phillipines, 1980).

Bricknell KS, Finegold SM. An improved method for assay of formic acid by gas-liquid chromatography. J Chromatogr. 151:374-378, 1978.

George WL, Sutter VL, Finegold SM. Toxigenicity and antimicrobial susceptibility of Clostridium difficile, a cause of antimicrobial agent-associated colitis. Curr Microbiol. 1:55-58, 1978.

Kirby BD, Snyder KM, Meyer RD, Finegold SM. Legionnaires' disease: Clinical features of 24 cases. Ann Intern Med. 89:297-309, 1978.

Goldstein EJC, Sutter VL, Finegold SM. Comparative susceptibilities of anaerobic bacteria to metronidazole, ornidazole and SC28538. Antimicrob Agents Chemother. 14:609-613, 1978.

Sutter VL, Oberhammer I, Kwok Y-Y, Finegold SM. Susceptibility of anaerobes to cefoxitin sodium and cephalothin. J Antimicrob Chemother. 4 (Suppl. B):41-46, 1978.

Goldstein EJC, Citron DM, Wield B, Blachman U, Sutter VL, Miller TA, Finegold SM. Bacteriology of human and animal bite wounds. J Clin Microbiol. 8:667-672, 1978.

Brook I, Finegold SM. Bacteriology of chronic otitis media. JAMA. 241:487-488, 1979.

Brook I, Finegold SM. Bacteriology and therapy of lung abscess in children. J Pediatr. 94:10-12, 1979.

Sutter VL, Kirby B, Finegold SM. In vitro activity of cefoxitin and parenterally administered cephalosporins against anaerobic bacteria. Rev Infect Dis. 1:218-223, 1979.

George WL, Sutter VL, Citron D, Finegold SM. Selective and differential medium for isolation of Clostridium difficile. J Clin Microbiol. 9:214-219, 1979.

Kwok Y-Y, Sutter VL, Oberhammer I, Finegold SM. The susceptibility of anaerobic bacteria to rosamicin, erythromycin and clindamycin and factors affecting the activity of rosamicin. J Antimicrob Chemother. 5:61-66, 1979.

Brook I, Pettit TH, Martin WJ, Finegold SM. Anaerobic and aerobic bacteriology of acute conjunctivitis. Ann Ophthalmol. 11:389-393, 1979.

Bricknell KS, Brook I, Finegold SM. Optimizing methylation conditions for gas liquid chromatography of lactic and succinic acid in biological samples. Chromatographia. 12:22-24, 1979.

Brook I, Barrett CT, Brinkman CR III, Martin WJ, Finegold SM. Aerobic and anaerobic bacterial flora of the maternal cervix and newborn gastric fluid and conjunctiva - prospective study. Pediatrics. 63:451-455, 1979.

Finegold SM. Disease due to nonsporeforming anaerobic bacteria, Chap. 151 In: Beeson PB, McDermott W, Wyngaarden JB, eds. Cecil Textbook of Medicine, 15th edit., Philadelphia: W.B. Saunders Co., 1979, p. 441-445.

Wheeler LA, Halula M, De Meo M, Sutter VL, Finegold SM. Metabolism of shikimic, quinic, and cyclohexane-carboxylc acids in germfree, conventional and gnotobiotic rats. Curr Microbiol. 2:85-90, 1979.

Rolfe RD, Finegold SM. Purification and characterization of a Clostridium difficile toxin. Infect Immun. 25:191-201, 1979.

Goldstein EJC, Lewis RP, Sutter VL, Finegold SM. Erythromycin for anaerobic pleuropulmonary and soft-tissue infections. JAMA. 242:435-438, 1979.

George WL, Volpicelli NA, Stiner DB, Richman DD, Liechty EJ, Mok HYI, Rolfe RD, Finegold SM. Relapse of pseudomembranous colitis and vancomycin therapy. N Engl J Med. 301:414-415, 1979.

George WL, Rolfe RD, Mulligan ME, Finegold SM. Infectious diseases 1979 -- antimicrobial agent-induced colitis: an update (editorial). J Infect Dis. 140:266-268, 1979.

Finegold SM. Antimicrobial therapy of anaerobic infections: a status report. Hosp Pract. 14:71-81, 1980.

. Finegold SM. Lung abscess, Chap. 44 In: Mandell GL, Douglas RG Jr, Bennett JE, eds. Principles and Practice of Infectious Diseases. New York: John Wiley & Sons, Inc., 1979, p. 509-515.

Finegold SM. Anaerobes in biliary tract infection (editorial). Arch Intern Med. 139: 1338, 1979.

Kirby BD, Snyder KM, Meyer RD, Finegold SM. Legionnaires' disease: Report of sixty-five nosocomially acquired cases and review of the literature. Medicine. 59:188-205, 1980.

Brook I, Finegold SM. Bacteriology of aspiration pneumonia in children. Pediatrics. 65:1115-1120, 1980.

George WL, Rolfe RD, Finegold SM. Treatment and prevention of antimicrobial agent-induced colitis and diarrhea. Gastroenterology. 79:366-372, 1980.

Goldstein EJC, Citron DM, Finegold SM. Dog bite wounds and infection: a prospective clinical study. Ann Emerg Med. 9:508-512, 1980.

Brook I, Martin WJ, Finegold SM. Bacteriology of tracheal aspirates in intubated newborn. Chest. 78:875-877, 1980.

Finegold SM, Gentry LO, Mogabgab W, Campbell SC, Skatrud J. Controlled comparative trial of bacampicillin and amoxicillin in therapy of bacterial infections of the lower respiratory tract. Rev Infect Dis. 3:150-153, 1981.

Finegold SM. Peritonitis, Chap. 15 In: Feigin RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases. Philadelphia: W.B. Saunders Co., 1981, p. 545-547.

Finegold SM. Clostridial intoxication and infection, Chap. 27 In: Feigin RD, Cherry JD, eds. Textbook of Pediatric Diseases. Philadelphia: W.B. Saunders Co., 1981, p. 837-843.

Rolfe RD, Halebian S, Finegold SM. Bacterial interference between Clostridium difficile and normal fecal flora. J Infect Dis. 143:470-475, 1981.

George WL, Sutter VL, Finegold SM. Beta-lactam antimicrobials for treatment of anaerobic infection--a review of in vitro activity and therapeutic efficiency. In: Salton M, Shockman GD, eds. Beta-lactam Antibiotics. New York: Academic Press, 1981, p. 493-530.

Brook I, Finegold SM. Aerobic and anaerobic bacteriology of cutaneous abscesses in children. Pediatrics. 67:891-895, 1981.

Finegold SM. Microflora of the gastrointestinal tract, Chap. 1 In: Wilson SE, Finegold SM, Williams RA, eds. Intra-Abdominal Infection. New York: McGraw-Hill Book Co., 1982, p. 1-21.

Serota AI, Finegold SM. Necrotizing soft tissue infections following abdominal surgery, Chap. 21 In: Wilson SE, Finegold SM, Williams RA, eds. Intra-Abdominal Infection. New York: McGraw-Hill Book Co., 1982, p. 328-345.

Finegold SM. Use of direct examination and selective media for rapid identification of clinically important anaerobes. In: Tilton RC, ed. Rapid Methods and Automation in Microbiology. Washington DC: American Society for Microbiology, 1982, p. 254-257.

Rolfe RD, Finegold SM. Clostridium difficile toxins: Structure and relation to diseases. In: Robbins JB, Hill JC, Sadoff JC, eds. Bacterial Vaccines, Vol. IV of Seminars in Infectious Disease. New York: Thieme-Stratton Inc., 1982, p. 25-31.

Finegold SM, Martin WJ. Diagnostic Microbiology, 6th edit., St. Louis: C.V. Mosby Co., 1982, 705 pp. (Spanish edition - Diagnostico Microbiologico. Buenos Aires: Editorial Medica Panamericana, 1988; Italian edition - Diagnostica Microbiologica. Padova: Piccin Nuova Libraria S.p.A., 1989)

George WL, Finegold SM. Bacterial infections of the lung. Chest. 81:502-507, 1982.

Finegold SM. Lung abscess and bronchiectasis, Chap. 45 In: Wyngaarden JB, Smith LH Jr, eds. Cecil Textbook of Medicine, 16th edit., Philadelphia: W.B. Saunders Co., 1982, p. 383-387.

George WL, Rolfe RD, Finegold SM. Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agents-associated diarrhea and miscellaneous conditions. J Clin Microbiol. 15:1049-1053, 1982.

Edelstein PH, Snitzer JB, Finegold SM. Isolation of Legionella pneumophila from hospital potable water specimens: Comparison of direct plating with guinea pig inoculation. J Clin Microbiol. 15:1092-1096, 1982.

Finegold SM, George JJ, eds. Proceedings of the Symposium, Economic Implications of Antimicrobial Therapy: Part 1 - Respiratory Tract Infections (45 pages), Part 2 - Genitourinary Tract Infections (69 pages). New York: Physicians Publications, Inc., 1982.

Rolfe RD, Finegold SM. Intestinal B-lactamase activity in ampicillin-induced, Clostridium difficile-associated ileocecitis. J Infect Dis. 147:227-235, 1983.

Finegold SM. Back to basics (Infectious Diseases Society of America Presidential Address, 1982). J Infect Dis. 147:367-371, 1983.

Owens WE, Finegold SM. Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan and N-formimidoyl thienamycin Antimicrob Agents Chemother. 23:626-629, 1983.

Finegold SM. Intra-abdominal abscess. In: Kass EH, Platt R, eds. Current Therapy in Infectious Diseases 1983-1984. Philadelphia: B.C. Decker, Inc., 1983, p. 240-242.

Finegold SM. Antimicrobial therapy of anaerobic infections, Chap. 3 In: Yetiv JZ, Bianchine JR, eds. Recent Advances in Clinical Therapeutics, Vol. III. New York: Grune & Stratton, Inc., 1983, p. 39-56.

Wexler H, Carter WT, Harris B, Finegold SM. Comparative in vitro activities of cefpiramide and apalcillin against anaerobic bacteria. Antimicrob Agents Chemother. 25:162-164, 1984.

Goldstein EJC, Citron DM, Finegold SM. Role of anaerobic bacteria in bite wound infections. Rev Infect Dis. 6 (Suppl. 1):S177-S183.

Finegold SM. Increasing resistance in anaerobes. Infect Surg. 3:332-335, 338, 1984.

Finegold SM. Antimicrobial therapy for anaerobic infections. Scand J Gastroenterol. 19:61-72, 1984.

Finegold SM. Lung abscess, Chap. 51 In: Mandell GL, Douglas RG, Bennett JE, eds. Principles and Practice of Infectious Diseases, 2nd edit., New York: John Wiley & Sons, 1985, p. 407-411.

Goldstein EJC, Reinhardt JF, Murray PM, Finegold SM. Animal and human bite wounds: a comparative study, augmentin vs. penicillin+/-dicloxacillin. Postgrad Med. Sept.-Oct., 1984, p. 105-110.

Finegold SM. Comparison of agents available for treating anaerobic infections. In: Finegold SM, ed., Kim J-P, Nambiar RM, assoc. eds. Proceedings of the First Far East Conference on Anaerobic Infections. Seoul, Korea, April 8-10, 1984. Southeast Asian J Surg. Suppl., Jan., p. 113-120, 1985.

Finegold SM. Susceptibility of anaerobic bacteria to thiamphenicol. Sex Trans Dis. 11 (Suppl.):430-431, 1984.

Shands HN, Ho JL, Meyer RD, Gorman GW, Edelstein PH, Mallison GF, Finegold SM, Fraser DW. Potable water as a source of Legionnaires' disease. JAMA. 253:1412-1416, 1985.

Wexler HM, Carter WT, Harris B, Finegold SM. In vitro activity of cefbuperazone against anaerobic bacteria. Antimicrob Agents Chemother. 27:674-676, 1985.

Wexler HM, Harris B, Carter WT, Finegold SM. In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria. Antimicrob Agents Chemother. 27:876-878, 1985.

George WL, Finegold SM. Clostridia in the human gastrointestinal flora, Chap. 1 In: Borriello SP, ed. Clostridia in Gastrointestinal Disease. Boca Raton, FL: CRC Press, Inc., 1985, p. 1-37.

Wexler H, Carter WT, Finegold SM. In-vitro activity of Sch 34343 against anaerobic bacteria. J Antimicrob Chemother. 15 (Suppl. C):173-176, 1985.

Wexler HM, Finegold SM. In vitro activity of imipenem against anaerobic bacteria. Rev Infect Dis. 7 (Suppl. 3):S417-S425, 1985.

Finegold SM, George WL, Mulligan ME. Anaerobic infections. Disease-a-Month, Part 1, October, 1985, 77 pp.; Part 2, November, 1985, 97 pp. Chicago: Year Book Medical Publishers, Inc.

Finegold SM, Johnson CC. Lower respiratory tract infection. Am J Med. 79:73-77, 1985.

Baker RJ, Donohue PE, Finegold SM, Johnson WC, Middleton JR, Monafo WW, Wilson SE. A prospective double-blind comparison of piperacillin, cephalothin and cefoxitin in the prevention of postoperative infections in patients undergoing intra-abdominal operations. Surg Gynecol Obstet. 161:409-415, 1985.

Cato EP, George WL, Finegold SM. Genus Clostridium Prazmowski 1880, 23AL. In: Holt JG, Sneath PHA, eds. Bergey's Manual of Systematic Bacteriology, Vol.2, 9th edit., Baltimore: Williams & Wilkins, 1986, pp.1141-1200.

Finegold SM. In Vitro comparison of newer beta-lactam agents against anaerobes. Proc 2nd International Symposium on Anaerobes, Tokyo, 1985, Medical Tribune Inc., Japan, 1986, pp.15-20.

Johnson CC, Reinhardt JF, Mulligan ME, George WL, Finegold SM. In vitro activities of 17 antimicrobial agents against the formate/fumarate-requiring anaerobic gram-negative bacilli. Diagn Microbiol Infect Dis 5: 269-272, 1986.

Reinhardt JF, Johnston L, Ruane P, Johnson CC, Ingram-Drake L, MacDonald K, Ward KW, Mathisen G, George WL, Finegold SM, Mulligan ME. A randomized, double blind comparison of sulbactam/ampicillin and clindamycin for the treatment of aerobic and aerobic-anaerobic infections. Rev Infect Dis 8(Suppl.5): S569-S575,1986

Finegold SM. Anaerobic infections and Clostridium difficile colitis emerging during antibacterial therapy. Scand J Infect Dis 49:160-164, 1986.

Prakash G, Wexler H, Muller EL, Grace PA, Pitt HA, Finegold SM. Effect of total parenteral nutrition on the intestinal microflora of prairie dogs. Microecol Ther 15:305-310, 1985.

Finegold SM. Normal human intestinal flora. International Meeting on Intestinal Flora in Health and Disease, Rome, 1985. Ann Ist Super Sanita 22:731-738, 1986.

Finegold SM, Arnon SS. Clostridial intoxication and infection. Chap. 18 In: Feigin RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases, 2nd edit. Philadelphia: W.B. Saunders Co., 1987, p. 1118-1125.

Goldstein EJC, Reinhardt JF, Murray PM, Finegold SM. Outpatient therapy of bite wounds. Demographic data, bacteriology and a prospective, randomized trial of amoxicillin/clavulanic acid vs. Penicillin +/- dicloxacillin. Int J Dermatol 26:123-127, 1987.

Finegold SM., guest ed. B-Lactamase Inhibition: Prophylaxis and Treatment of Intraabdominal and Female Genital Tract Infections with Sulbactam/Ampicillin. Therapeutic Conferences. Secaucus, NJ: Advanced Therapeutic Communications International, Publ., 1987, 36pp.

Finegold SM. Anaerobic bacteria. Their role in infection and their management. Postgrad Med 81:141-147, 1987.

Johnson CC, Finegold SM. Uncommonly encountered, motile,anaerobic gram-negative bacilli associated with infection. Rev Infect Dis 9:1150-1162, 1987.

Wexler HM, Finegold SM. In vitro activity of selected antibiotics against anaerobes. Clin Ther 10, Suppl. A:12-18, 1987.

Wexler HM, Finegold SM. In vitro activity of cefoperazone plus sulbactam compared with that of other antimicrobial agents against anaerobic bacteria. Antimicrob Agents Chemother 32:403-406, 1988.

Wexler HM, Finegold SM. Comparative in vitro activity of the new macrolide A-56268 against anaerobic bacteria. Eur J Clin Microbiol 6:492-494, 1988.

Wexler HM, Finegold SM. In vitro activity of cefotetan compared with that of other antimicrobial agents against anaerobic bacteria. Antimicrob Agents Chemother 32:601-604, 1988.

Finegold SM, NCCLS Working Group on Anaerobic Susceptibility Testing. Susceptibility testing of anaerobic bacteria. J Clin Microbiol 26:1253-1256, 1988.

Rolfe RD, Finegold SM, eds. Clostridium difficile: Its Role in Intestinal Disease. Orlando, FL:Academic Press, p. 1-408, 1988.

Finegold SM. Anaerobic infections of lung and pleura, Chap. 93. In: Fishman AP, ed. Pulmonary Diseases and Disorders. 2nd edit. New York: McGraw-Hill, 1988, p. 1505-1516.

Wexler M, Finegold SM. Incidence and importance of resistance in anaerobic microorganisms. In: Neu HE, ed. Issues and Answers in Antibiotic Resistance. Mechanisms of Beta-Lactam Resistance. London: Keith Littlewood Assoc., 1988, 4pp.

Finegold SM. Aspiration pneumonia, lung abscess, and empyema. In: Pennington JE, ed. Respiratory Infections: Diagnosis and Management, 2nd edit. New York: Raven Press, 1988, p. 264-275.

Wexler HM, Reeves D, Finegold SM. Antibiotic susceptibility testing of anaerobic organisms using the agar dilution method: Comparison of three techniques. Clin Ther 10:747-760, 1988.

Finegold SM, George WL, eds. Anaerobic Infections in Humans. San Diego: Academic Press, 1989, 851 pp.

Finegold SM, Working Group on Antimicrobial Susceptibility Testing of Anaerobic Bacteria. National Committee for Clinical Laboratory Standards. Methods for antimicrobial susceptibility testing of anaerobic bacteria -- second edition; Tentative Standard. NCCLS publication M11-T2. Villanova, PA: NCCLS, 1989. Approved Standard. NCCLS Document M11-T2. Vol. 10, No. 15, 1990.

Baron EJ, Summanen P, Downes J, Roberts MC, Wexler H, Finegold SM. Bilophila wadsworthia, gen.nov. and sp.nov., a unique gram-negative anaerobic rod recovered from appendicitis specimens and human faeces. J Gen Microbiol 135:3405-3411, 1989.

Wexler HM, Reeves D, Finegold SM. Effects of inoculum size and medium on activity of seven antimicrobial agents against Bacteroides fragilis strains. Clin Ther 11:828-833, 1989.

Bennion RS, Baron EJ, Thompson Jr. JE, Downes J, Summanen P, Finegold SM. The bacteriology of gangrenous and perforated appendicitis -- revisited. Ann Surg 211:165-171, 1990.

Cuchural GJ Jr, Tally FP, Jacobus NV, Cleary T, Finegold SM, Hill G, Iannini P, O'Keefe JP, Pierson C. Comparative activities of newer ß-lactam agents against members of the Bacteroides fragilis group. Antimicrob Agents Chemother 34:479-480, 1990.

Bennion RS, Thompson JE, Baron EJ, Finegold SM. Gangrenous and perforated appendicitis with peritonitis -- treatment and bacteriology. Clin Ther 12 (Suppl C):31-44, 1990.

Wexler HM, Lavin PT, Molitoris E, Finegold SM. Statistical analysis of the effects of trial, reader, and replicates on MIC determination for cefoxitin. Antimicrob Agents Chemother 34:2246-2249, 1990.

Baron EJ, Finegold SM. Bailey and Scott's Diagnostic Microbiology, 8th edit. St. Louis: C.V. Mosby Co., 1990, p. 1-861.

Wexler HM, Molitoris E, Finegold SM. Effect of β-lactamase inhibitors on the activities of various β-lactam agents against anaerobic bacteria. Antimicrob Agents Chemother 35:1219-1224, 1991.

Finegold SM. Role of anaerobic bacteria in infections of the tonsils and adenoids. In: Workshop on the Role of Anaerobic Bacteria in Infections of the Upper Respiratory Tract-Head and Neck. Ann Otol Rhinol Laryngol. 100 (Suppl 154):30-33, 1991.

Finegold SM. Anaerobic gram-negative rods: Bacteroides, Prevotella, Porphyromonas, Fusobacterium, Bilophila. Chap. 231 In: Gorbach SL, Bartlett JG, Blacklow NR, eds. Infectious Diseases. Philadelphia: W.B. Saunders Company, 1992, p. 1571-1589.

Wexler HM, Molitoris E, Finegold SM. In vitro activities of three of the newer quinolones against anaerobic bacteria. Antimicrob Agents Chemother 36:239-243, 1992.

Finegold SM, Molitoris E, Reeves D, Wexler HM. In-vitro activity of temafloxacin against anaerobic bacteria: a comparative study. J Antimicrob Chemother 28 (Suppl C):25-30, 1991.

Baron EJ, Curren M, Henderson G, Jousimies-Somer H, Lee K, Lechowitz K, Strong CA, Summanen P, Tunér K, Finegold SM. Bilophila wadsworthia isolates from clinical specimens. J Clin Microbiol 30:1882-1884, 1992.

Summanen P, Wexler HM, Finegold SM. Antimicrobial susceptibility testing of Bilophila wadsworthia by using triphenyltetrazolium chloride to facilitate endpoint determination. Antimicrob Agents Chemother. 36:1658-1664, 1992.

Finegold SM. Host factors predisposing to anaerobic infections. FEMS Immunol Med Microbiol. 6:159-164, 1993.

Finegold SM. A century of anaerobes: a look backward and a call to arms. Clin Infect Dis. 16 (Suppl.4):S453-S457, 1993.

Wexler HM, Molitoris E, Finegold SM. In vitro activity of Bay Y3118 against anaerobic bacteria. Antimicrob Agents Chemother 37:2509-2513, 1993.

(Finegold SM, Working Group on Antimicrobial Susceptibility Testing of Anaerobic Bacteria) National Committee for Clinical Laboratory Standards. Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria--Third Edition; Approved Standard. NCCLS Document M11-A3. Villanova, PA: NCCLS, 1993. Vol. 13, No. 26, 1993.

Baron EJ, Peterson LR, Finegold SM Bailey & Scott's Diagnostic Microbiology, 9th edit. St. Louis: C.V. Mosby Co., 1994, p. 1-958.

Wexler HM, Molitoris E, Finegold SM. In vitro activity of grepafloxacin (OPC-17116) against anaerobic bacteria. Diagn Microbiol Infect Dis 19:129-133, 1994.

Wexler HM, Molitoris E, Reeves D, Finegold SM. In vitro activity of DU-6859a against anaerobic bacteria. Antimicrob Agents Chemother 38:2504-2509, 1994.

Wexler HM, Molitoris E, Finegold SM. In vitro activities of two new glycylcyclines, N, N-dimethylglycylamido derivatives of minocycline and 6-demethyl-6-deoxytetracycline, against 339 strains of anaerobic bacteria. Antimicrob Agents Chemother 38:2513-2515, 1994.

Wexler HM, Molitoris E, Reeves D, Finegold SM. In-vitro activity of clinafloxacin (CI-960) and PD 131628-2 against anaerobic bacteria. J Antimicrob Chemother 34:579-584, 1994.

Wexler HM, Molitoris E, Finegold SM. The in-vitro activity of L-627 against anaerobic bacteria. J Antimicrob Chemother 33:629-634, 1994.

Finegold SM. Anaerobic bacteria: General concepts. Chap. 221 In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 4th edit., New York, Churchill Livingstone, 1995, pp. 2156-2173.

Shah HN, Gharbia SE, Scully C, Finegold SM. Oligonucleotide probes to the 16S ribosomal RNA: implications of sequence homology and secondary structure with particular reference to the oral species Prevotella intermedia and Prevotella nigrescens. Oral Dis. 1:32-36, 1995.

Molitoris D, Summanen P, Finegold SM, Herman J, Wexler HM. Differentiation of Bacteroides gracilis, Bacteroides gracilis-like organisms and Campylobacter species on the basis of dehydrogenase patterns. Clin Infect Dis 20 (Suppl. 2):S128-S129, 1995.

Baron EJ, Strong CA, McTeague M, Väisänen M-L, Finegold SM. Survival of anaerobes in original specimens transported by overnight mail services. Clin Infect Dis 20 (Suppl. 2):S174-S177, 1995.

Jousimies-Somer HR, Summanen P, Finegold SM. Bacteroides levii-like organisms isolated from clinical specimens. Clin Infect Dis 20 (Suppl. 2):S208-S209, 1995.

Summanen PH, Talan DA, Strong C, McTeague M, Bennion R, Thompson JE Jr., Väisänen M-L, Moran G, Winer M, Finegold SM. Bacteriology of skin and soft tissue infections. Comparison of infections in intravenous drug users and individuals with no history of intravenous drug use. Clin Infect Dis 20 (Suppl. 2):S279-S282, 1995.

Wexler HM, Reeves D, Summanen P, Molitoris E, McTeague M, Duncan J, Wilson KH, Finegold SM. Sutterella wadsworthensis gen.nov., sp.nov., bile-resistant microaerophilic Campylobacter gracilis-like, clinical isolates. Int J Syst Bacteriol 46:252-258, 1996.

Tunér K, Wexler HM, Reeves D, Finegold SM. Penicillin-binding proteins in Fusobacterium species. Anaerobe 2:155-162, 1996.

Könönen E, Väisänen M-L, Finegold SM, Heine R, Jousimies-Somer H. Cellular fatty acid analysis and enzyme profiles of Porphyromonas catoniae -- a frequent colonizer of the oral cavity in children. Anaerobe 2:329-335, 1996.

Wexler HM, Molitoris E, Molitoris D, Finegold SM. In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria. Antimicrob Agents Chemother. 40:2232-2235, 1996.

Finegold SM, Jousimies-Somer H. Recently described clinically important anaerobic bacteria: medical aspects. Clin Infect Dis. 25 (Suppl 2):S 88-93, 1997.

Molitoris E, Wexler HM, Finegold SM. Sources and antimicrobial susceptibilities of Campylobacter gracilis and Sutterella wadsworthensis. Clin Infect Dis. 25 (Suppl 2):S 264-5. 1997.

Mosca A, Summanen P, Finegold SM, DeMichele G, Miragliotta G. Cellular fatty acid composition, soluble-protein profile, and antimicrobial resistance pattern of Eubacterium lentum. J Clin Microbiol 36:752-755, 1998.

Wexler HM, Molitoris E, Molitoris D, Finegold SM. In vitro activity of levofloxacin against a selected group of anaerobic bacteria isolated from skin and soft tissue infections. Antimicrob Agents Chemother. 42:984-986, 1998.

Wexler HM, Finegold SM. Current susceptibility patterns of anaerobic bacteria. Yonsei Med.J. 39:495-501, 1998.

Finegold SM. Disease related to intestinal anaerobes. Proceedings of the 28th Annual Meeting of the Japanese Association of Anaerobic Infection Research. J. Japanese Assoc Anaer Infect Res. 28:206-213, 1998.

Finegold SM. In vitro efficacy of β-lactam/β-lactamase inhibitor combinations against bacteria involved in mixed infections. Internat J Antimicrob Agents 12:S9- S14, 1999.

Read E, Finegold SM. Molecular methods used in the diagnosis and research of anaerobic bacteria. Mikrobiyol.Bult.2000 34:59-70, 2000.

Wexler HM, Molitoris D, Finegold SM. In vitro activities of MK-826 (L-749, 345) against 363 strains of anaerobic bacteria. Antimicrob.Agents Chemother. 44:2222-4, 2000.

Wexler HM, Molitoris E, Molitoris D, Finegold SM. In vitro activity of moxifloxacin against 179 strains of anaerobic bacteria found in pulmonary infections. Anaerobe 6:227-31, 2000.

Wexler HM, Molitoris E, Molitoris D, Finegold SM. In vitro activity of telithromycin (HMR 3647) against 502 strains of anaerobic bacteria. J. Antimicrob.Chemother. 47: 467-469, 2001.

Wexler HM, Molitoris D, Finegold SM. In vitro activity of gatifloxacin against 238 strains of anaerobic bacteria. Anaerobe. 7: 285-289, 2001.

Jousimies-Somer HR, Summanen P, Citron DM, Baron EJ, Wexler HM, Finegold SM, eds., Wadsworth-KTL Anaerobic Bacteriology Manual, 6th edit., Star Publ. Co., Belmont, CA, 287 pp., 2002.

Finegold SM, Molitoris D, Phan VT, Vaisanen M-L, Wexler HM. Activities of ABT- 773 against microaerophilic and fastidious organisms. Antimicrob. Agents Chemother. 46: 2716-2719, 2002.

Finegold SM, Flynn MJ, Rose FV, Jousimies-Somer H, Jakielaszek C, McTeague M, Wexler HM, Berkowitz E, Wynne B. Bacteriologic findings associated with chronic bacterial maxillary sinusitis in adults. Clin.Infect.Dis. 35: 428-433, 2002.

Roe DE, Finegold SM, Citron DM, Goldstein EJC, Wexler HM, Rosenblatt JE, Cox ME, Jenkins SG, Hecht DW. Multilaboratory comparison of anaerobe susceptibility results using 3 different agar media. Clin.Infect.Dis. 35 (Suppl.1): S40-S46, 2002.

Finegold SM, Molitoris D, Phan VT, Vaisanen M-L, Wexler HM. Activity of ABT- 773 against bowel flora organisms. Anaerobe 8: 49-54, 2002.

Wexler HM, Molitoris D, St.John S, Vu A, Read EK, Finegold SM. In vitro activities of faropenem against 579 strains of anaerobic bacteria. Antimicrob Agents Chemother. 46: 3669-3675, 2002.

Song Y, Liu C, McTeague M, Finegold SM. 16S ribosomal DNA sequence-based analysis of clinically significant gram positive anaerobic cocci. J.Clin.Microbiol. 41:1363-1369, 2003.

Liu C, Song Y, McTeague M, Vu AW, Wexler H, Finegold SM. Rapid identification of the species of the Bacteroides fragilis group by multiplex PCR assays using group- and species-specific primers. FEMS Microbiol Letters 222:9-16, 2003.

Song Y, Liu C, McTeague M, Vu A, Liu JY, Finegold SM. Rapid identification of gram-positive anaerobic coccal species originally classified in the genus Peptostreptococcus by multiplex PCR assays using genus- and species-specific primers. Microbiology 149:1719-1727, 2003.

Golan Y, McDermott LA, Jacobus NV, Goldstein EJC, Finegold S, Harrell LJ, Hecht DW, Jenkins SG, Pierson C, Venezia R, Rihs J, Iannini P, Gorbach SL, Snydman DR. Emergence of fluoroquinolone resistance among Bacteroides species. J.Antimicrob.Chemother. 52:208-213, 2003.

Lawson PA, Song Y, Liu C, Molitoris DR, Vaisanen M-L, Collins MD, Finegold SM. Anaerotruncus colihominis gen.nov., sp.nov., from human faeces. Int.J.Syst.Evol.Microbiol. 54:413-417, 2004.

Finegold SM, Lawson PA, Vaisanen M-L, Molitoris DR, Song Y, Liu C, Collins MD. Anaerofustis stercorihominis gen.nov., sp.nov., from human feces. Anaerobe. 10:41- 45, 2004.

Song YL, Liu CX, McTeague M, Summanen P, Finegold SM. Clostridium bartlettii sp.nov., isolated from human faeces. Anaerobe 10:179-84, 2004.

Finegold SM, Vaisanen M-L, Rautio M, Eerola E, Summanen P, Molitoris D, Song Y, Liu C, Jousimies-Somer H. Porphyromonas uenonis sp.nov., a pathogen for humans distinct from P. asaccharolytica and P. endodontalis. J.Clin.Microbiol. 42:5298- 5301, 2004.

Song Y, Liu CX, McTeague M, Finegold SM. "Bacteroides nordii" sp.nov., and "Bacteroides salyersae" sp.nov. isolated from clinical specimens of human intestinal origin. J.Clin.Microbiol. 42:5565-5570, 2004.

Falsen E, Collins MD, Welinder-Olsson C, Song Y, Finegold SM, Lawson PA. Fastidiosipila snaguinis gen.nov., sp.nov., a new Gram-positive, coccus-shaped organism from human blood. Int.J.Syst.Evol.Microbiol. 55:853-8, 2005.

Song Y, Liu C, Bolanos M, Lee J, McTeague M, Finegold SM. Evaluation of 16S rRNA sequencing and reevaluation of a short biochemical scheme for identification of clinically significant Bacteroides species. J.Clin.Microbiol. 43: 1531-1537, 2005.

Summanen PH, Durmaz B, Vaisanen M-L, Liu C, Molitoris D, Eerla E, Helander IM, Finegold SM. Porphyromonas somerae sp.nov., a pathogen isolated from humans and distinct from Porphyromonas levii. J.Clin.Microbiol. 43: 4455-9, 2005.

Song Y, Liu C, Lee J, Bolanos M, Vaisanen M-L, Finegold SM. "Bacteroides goldsteinii sp.nov." isolated from clinical specimens of human intestinal origin. J.Clin.Microbiol. 43: 4522-7, 2005.

Molitoris D, Vaisanen M-L, Bolanos M, Finegold SM. In vitro activities of DX-619 and four comparator agents against 376 anaerobic bacterial isolates. Antimicrob. Agents Chemother. 50: 1887-9, 2006.

Song Y, Kononen E, Rautio M, Liu C, Bryk A, Eerola E, Finegold SM. Alistipes onderdonkii sp.nov. and Alistipes shahii sp.nov., of human origin. Int.J.Syst.Evol.Microbiol. 56: 1985-90, 2006.

Song Y, Liu C, Finegold SM. Development of a flow chart for identification of gram- positive anaerobic cocci in the clinical laboratory. J.Clin.Microbiol. 45: 512-6, 2007.

Avila-Campos MJ, Liu C, Song Y, Rowlinson M-C, Finegold SM. Determination of bft gene subtypes in Bacteroides fragilis clinical isolates. J.Clin.Microbiol. 45: 1336- 8, 2007.

Song Y, Liu C, Finegold SM. Peptoniphilus gorbachii sp.nov., Peptoniphilus olsenii sp.nov., and Anaerococcus murdochii sp.nov. isolated from clinical specimens of human origin. J Clin Microbiol 45:1746-52, 2007.

Liu C, Finegold SM, Song Y, Lawson PA. Reclassification of Clostridium coccoides, Ruminococcus hansenii, Ruminococcus hydrogenotrophicus, Ruminococcus luti, Ruminococcus productus and Ruminococcus schinkii as Blautia coccoides gen.nov., comb.nov., Blautia hansenii comb.nov., Blautia hydrogenotrophica comb.nov., Blautia luti comb.nov., Blautia producta comb.nov., Blautia schinkii comb.nov. and description of Blautia wexlerae sp.nov., isolated from human faeces. Int.J.Syst.Evol.Microbiol. 58: 1896-1902, 2008.

Summanen PH, Lawson PA, Finegold SM. Porphyromonas bennonis sp.nov., isolated from human clinical specimens. IJSEM. 59: 1727-32, 2009.

Summanen PH, Rowlinson M-C, Wooton J, Finegold SM. Evaluation of genotypic and phenotypic methods for differentiation of the members of the Anginosus group streptococci. Eur.J.Clin.Microbiol.Infect.Dis. 28: 1123-1128, 2009.

Zheng G, Summanen PH, Talan D, Bennion R, Rowlinson M-C, Finegold SM. Phenotypic and molecular characterization of Solobacterium moorei isolates from patients with wound infection. J.Clin.Microbiol. 48: 873-876, 2010.

Kim K-S, Rowlinson M-C, Bennion R, Liu C, Talan D, Summanen P, Finegold SM. Characterization of Slackia exigua isolated from human wound infections, including abscesses of intestinal origin. J.Clin.Microbiol. 48:1070-1075, 2010.

Ulger-Toprak N, Liu C, Summanen PH, Finegold SM. Murdochiella asaccharolytica gen.nov., sp.nov., a gram-stain-positive, anaerobic coccus isolated from human wound specimens. Int.J.Syst.Evol.Microbiol. 60: 1013-1016, 2010.

Ulger-Toprak N, Summanen PH, Liu C, Rowlinson M-C, Finegold SM. Gemella asacharolytica sp.nov., isolated from human clinical specimens. Int.J.Syst.Evol.Microbiol. 60: 1023-1026, 2010.

Tong J, Liu C, Summanen PH, Xu H, Finegold SM. Corynebacterium pyruviciproducens sp.nov., a pyruvic acid producer. Int.J.Syst.Evol.Microbiol. 60: 1135-1140, 2010.

Song Y, Liu C, Finegold SM. Genus I. Bacteroides Castellani and Chalmers 1919, 959 AL. emend. Shah and Collins, 1989, 85. In Bergey's Manual of Systematic Bacteriology, 2nd edit., vol. 4. The Bacteroidetes, Spirochaetes,Tenericutes (Mollicutes), Acidobacteria, Fibrobacteres, Fusobacteria, Dictyoglomi, Gemmatimonadetes, , Lentisphaerae, Verrucomicrobia, Chlamydiae, and Planctomycetes. Krieg NR, Staley JT, Brown DR, Hedlund BP, Paster BJ, Ward NL, Ludwig W, Whitman WB, eds., Springer, New York, 2011, p. 27-41.

Könönen E, Song Y, Rautio M, Finegold SM. Genus II. Alistipes Rautio, Eerola, Väisänen-Tunkelrott, Molitoris, Lawson, Collins and Jousimies-Somer 2003 b, 1701VP (Effective publication: Alistipes Rautio, Eerola, Väisänen-Tunkelrott, Molitoris, Lawson, Collins and Jousimies-Somer 2003 a, 186. In Bergey's Manual of Systematic Bacteriology, 2nd edit., vol. 4. The Bacteroidetes, Spirochaetes,Tenericutes (Mollicutes), Acidobacteria, Fibrobacteres, Fusobacteria, Dictyoglomi, Gemmatimonadetes, , Lentisphaerae, Verrucomicrobia, Chlamydiae, and Planctomycetes. Krieg NR, Staley JT, Brown DR, Hedlund BP, Paster BJ, Ward NL, Ludwig W, Whitman WB, eds., Springer, New York, 2011, p. 56-61.

Summanen P, Finegold SM. Family IV. Porphyromonadaceae fam.nov. Genus I. Porphyromonas Shah and Collins 1988, 129 VP emend. Willems and Collins 1995, 580. In Bergey's Manual of Systematic Bacteriology, 2nd edit., vol. 4. The Bacteroidetes, Spirochaetes,Tenericutes (Mollicutes), Acidobacteria, Fibrobacteres, Fusobacteria, Dictyoglomi, Gemmatimonadetes, , Lentisphaerae, Verrucomicrobia, Chlamydiae, and Planctomycetes. Krieg NR, Staley JT, Brown DR, Hedlund BP, Paster BJ, Ward NL, Ludwig W, Whitman WB, eds., Springer, New York, 2011, p. 62-70.

Nichols FC, Yao X, Bajrami B, Downes J, Finegold SM, Knee E, Gallagher JJ, Housley WJ, Clark RB. Phosphorylated dihydroceramides from common human bacteria are recovered in human tissues. PLoS ONE 6: e16771, 2011.

Tong J, Liu C, Summanen P, Xu H, Finegold SM. Application of quantitative real- time PCR for rapid identification of Bacteroides fragilis group and related organisms in human wound samples. Anaerobe 17: 64-68, 2011.

Ulger-Toprak U, Lawson PA, Summanen P, O'Neal L, Finegold SM. Peptoniphilus duerdenii sp.nov., and Peptoniphilus koenoeneniae sp.nov. isolated from human clinical specimens. IJSEM. [Epub ahead of print]

©2012-2016 All Rights Reserved